Patents by Inventor Thomas Kohlmann
Thomas Kohlmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10928579Abstract: A sheet including a reflector having a first surface, a second surface opposite the first surface, and a third surface; a first selective light modulator layer external to of the first surface of the reflector; and a second selective light modulator layer external to the second surface of the reflector; wherein the third surface of the reflector is open is disclosed. A method of making a sheet is also disclosed.Type: GrantFiled: June 26, 2017Date of Patent: February 23, 2021Assignee: VIAVI SOLUTIONS INC.Inventors: Johannes Seydel, Mark Tevis, Kangning Liang, Jaroslaw Zieba, Paul Thomas Kohlmann, Jeffrey James Kuna
-
Patent number: 10918819Abstract: Described are nasal cannulas that improve the precision of the delivered dose for nitric oxide therapy by reducing the dilution of nitric oxide. The nasal cannulas may reduce the total volume and potential for retrograde flow during nitric oxide therapy through the design of the specific dimensions of the flow path and/or having check valves in the nitric oxide delivery line and/or having a flapper or umbrella valve dedicated to nitric oxide delivery. The nasal cannulas may also use materials that limit oxygen diffusion through the cannula walls. The nosepiece for these cannulas may be manufactured by a molding technique.Type: GrantFiled: October 23, 2017Date of Patent: February 16, 2021Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Craig Flanagan, Simon Freed, John Klaus, Thomas Kohlmann, Martin D. Meglasson, Manesh Naidu, Parag Shah
-
Patent number: 10905845Abstract: Described are methods for safer nitric oxide delivery, as well as apparatuses for performing these methods. The methods may include detecting the presence or absence of a nasal cannula, and stopping the delivery of nitric oxide or providing an alert if the cannula is disconnected. The methods may also include purging the nasal cannula if it is reconnected after a disconnection or if it is replaced by a new cannula. Other methods pertain to automatic purging of the delivery conduit if the elapsed time between successive deliveries of therapeutic gas exceeds a predetermined period of time.Type: GrantFiled: January 23, 2017Date of Patent: February 2, 2021Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Jaron M. Acker, Thomas Kohlmann
-
Patent number: 10882280Abstract: An article including a magnetic-containing layer having a first surface and a second surface opposite the first; a first reflector layer external to the first surface of the magnetic-containing layer; a second reflector layer external to the second surface of the magnetic-containing layer; a first selective light modulator layer external to the first reflector layer; a second selective light modulator layer external to the second reflector layer; a first absorber layer external to the first selective light modulator layer; and a second absorber layer external to the second selective light modulator layer; wherein at least one of the first and second selective light modulator layers comprises at least one of a curing agent, and at least one coating aid is disclosed. Methods of making the disclosed article are also disclosed.Type: GrantFiled: September 30, 2019Date of Patent: January 5, 2021Assignee: VIAVI SOLUTIONS INC.Inventors: Johannes Seydel, Mark Tevis, Kangning Liang, Jeffrey James Kuna, Jaroslaw Zieba, Paul Thomas Kohlmann
-
Publication number: 20200398019Abstract: Described are systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness. Systems and methods of the present disclosure can generate and/or provide desired flow profiles with various shapes and/or properties by configuring, modifying, optimizing, and/or factoring in aspects of at least one fixed flow rate assembly of a therapeutic gas delivery system such as, but not limited to, spatial relationships of elements of the fixed flow rate assembly, rate of valve closure and opening, latent flows, transient wave generation and/or propagation, to name a few.Type: ApplicationFiled: August 31, 2020Publication date: December 24, 2020Applicant: INO Therapeutics LLCInventors: Thomas Kohlmann, John Klaus
-
Patent number: 10758703Abstract: Described are systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness. Systems and methods of the present disclosure can generate and/or provide desired flow profiles with various shapes and/or properties by configuring, modifying, optimizing, and/or factoring in aspects of at least one fixed flow rate assembly of a therapeutic gas delivery system such as, but not limited to, spatial relationships of elements of the fixed flow rate assembly, rate of valve closure and opening, latent flows, transient wave generation and/or propagation, to name a few.Type: GrantFiled: October 19, 2015Date of Patent: September 1, 2020Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Thomas Kohlmann, John Klaus
-
Publication number: 20200172742Abstract: A composition including a first color shifting pigment having a first color shift that extends from a starting color at normal through a plurality of colors as a viewing angle is increased to a final color, wherein the first color shift rotates counterclockwise relative to, and about, an origin of the L*a*b* color space; and a color filter that transmits a portion of the first color shift of the first color shifting pigment and absorbs a remainder of the first color shift of the first color shifting pigment; wherein the composition has a second color shift different from the first color shift; and wherein the second color shift has a first portion that rotates counterclockwise relative to the origin and a second portion that rotates clockwise relative to the origin is disclosed. A security device including the composition is included. A method of making the composition and a method of authenticating the security device are also disclosed.Type: ApplicationFiled: December 3, 2019Publication date: June 4, 2020Applicant: VIAVI SOLUTIONS INC.Inventors: Cornelis Jan DELST, Paul Thomas KOHLMANN
-
Publication number: 20200171259Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.Type: ApplicationFiled: February 10, 2020Publication date: June 4, 2020Applicant: Mallinckrodt Hospital Products IP LimitedInventors: Craig Flanagan, Simon Freed, John Klaus, Thomas Kohlmann, Martin D. Meglasson, Manesh Naidu, Parag Shah
-
Patent number: 10556082Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.Type: GrantFiled: January 23, 2017Date of Patent: February 11, 2020Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Craig Flanagan, Simon Freed, John Klaus, Thomas Kohlmann, Martin D. Meglasson, Manesh Naidu, Parag Shah
-
Publication number: 20200023615Abstract: An article including a magnetic-containing layer having a first surface and a second surface opposite the first; a first reflector layer external to the first surface of the magnetic-containing layer; a second reflector layer external to the second surface of the magnetic-containing layer; a first selective light modulator layer external to the first reflector layer; a second selective light modulator layer external to the second reflector layer; a first absorber layer external to the first selective light modulator layer; and a second absorber layer external to the second selective light modulator layer; wherein at least one of the first and second selective light modulator layers comprises at least one of a curing agent, and at least one coating aid is disclosed. Methods of making the disclosed article are also disclosed.Type: ApplicationFiled: September 30, 2019Publication date: January 23, 2020Applicant: VIAVI SOLUTIONS INC.Inventors: Johannes SEYDEL, Mark TEVIS, Kangning LIANG, Jeffrey James KUNA, Jaroslaw ZIEBA, Paul Thomas KOHLMANN
-
Publication number: 20200002542Abstract: A composition includes magnetic particles having a median particle size ranging from about 10 to about 30 microns; and reflective particles having a median particle size ranging from about 1 to about 9 microns, wherein the reflective particles have a lightness at least 10 points higher than the lightness of the magnetic particles. A method of making the composition is also disclosed.Type: ApplicationFiled: June 27, 2019Publication date: January 2, 2020Applicant: VIAVI SOLUTIONS INC.Inventors: Cornelis Jan DELST, Paul Thomas KOHLMANN
-
Patent number: 10493724Abstract: An article including a magnetic-containing layer having a first surface and a second surface opposite the first; a first reflector layer external to the first surface of the magnetic-containing layer; a second reflector layer external to the second surface of the magnetic-containing layer; a first selective light modulator layer external to the first reflector layer; a second selective light modulator layer external to the second reflector layer; a first absorber layer external to the first selective light modulator layer; and a second absorber layer external to the second selective light modulator layer; wherein at least one of the first and second selective light modulator layers comprises at least one of a curing agent, and at least one coating aid is disclosed. Methods of making the disclosed article are also disclosed.Type: GrantFiled: December 18, 2018Date of Patent: December 3, 2019Assignee: VIAVI SOLUTIONS INC.Inventors: Johannes Seydel, Mark Tevis, Kangning Liang, Jeffrey James Kuna, Jaroslaw Zieba, Paul Thomas Kohlmann
-
Publication number: 20190328992Abstract: Described are methods and devices for therapeutic or medical gas delivery that utilize at least one proportional control valve and at least one binary control valve. The proportional control valve may be in series with the binary control valve to provide a valve combination capable of pulsing therapeutic gas at different flow rates, depending on the setting of the proportional control valve. Alternatively, the proportional control valve and binary control valve may be in parallel flow paths.Type: ApplicationFiled: July 8, 2019Publication date: October 31, 2019Inventors: Jaron M. Acker, Thomas Kohlmann, Craig R. Tolmie
-
Publication number: 20190321578Abstract: The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO2-to-NO reactor cartridge and/or a breakthrough of NO2, and providing an indication of the remaining useful life and/or breakthrough.Type: ApplicationFiled: July 3, 2019Publication date: October 24, 2019Inventors: Jaron M. Acker, Thomas Kohlmann
-
Patent number: 10384031Abstract: The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO2-to-NO reactor cartridge and/or a breakthrough of NO2, and providing an indication of the remaining useful life and/or breakthrough.Type: GrantFiled: June 19, 2015Date of Patent: August 20, 2019Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Jaron M. Acker, Thomas Kohlmann
-
Publication number: 20190225006Abstract: There is disclosed a security device, including a substrate; a first color-shifting pigment on a first region of the substrate; and a second pigment, including at least three dielectric layers, on a second region of the substrate; wherein the first color-shifting pigment and the second pigment color match at a first viewing angle. Methods of making and using the security device are also disclosed.Type: ApplicationFiled: January 21, 2019Publication date: July 25, 2019Applicant: VIAVI SOLUTIONS INC.Inventors: Paul Thomas KOHLMANN, Cornelis Jan DELST
-
Patent number: 10342948Abstract: Described are methods and devices for therapeutic or medical gas delivery that utilize at least one proportional control valve and at least one binary control valve. The proportional control valve may be in series with the binary control valve to provide a valve combination capable of pulsing therapeutic gas at different flow rates, depending on the setting of the proportional control valve. Alternatively, the proportional control valve and binary control valve may be in parallel flow paths.Type: GrantFiled: March 18, 2014Date of Patent: July 9, 2019Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Jaron Acker, Thomas Kohlmann, Craig R. Tolmie
-
Patent number: 10328231Abstract: Described are methods and devices for therapeutic or medical gas delivery that utilize at least one proportional control valve and at least one binary control valve. The proportional control valve may be in series with the binary control valve to provide a valve combination capable of pulsing therapeutic gas at different flow rates, depending on the setting of the proportional control valve. Alternatively, the proportional control valve and binary control valve may be in parallel flow paths.Type: GrantFiled: April 10, 2017Date of Patent: June 25, 2019Assignee: Mallinckrodt Hospital Products IP LimitedInventors: Jaron M. Acker, Thomas Kohlmann, Craig R. Tolmie
-
Publication number: 20190143645Abstract: An article including a magnetic-containing layer having a first surface and a second surface opposite the first; a first reflector layer external to the first surface of the magnetic-containing layer; a second reflector layer external to the second surface of the magnetic-containing layer; a first selective light modulator layer external to the first reflector layer; a second selective light modulator layer external to the second reflector layer; a first absorber layer external to the first selective light modulator layer; and a second absorber layer external to the second selective light modulator layer; wherein at least one of the first and second selective light modulator layers comprises at least one of a curing agent, and at least one coating aid is disclosed. Methods of making the disclosed article are also disclosed.Type: ApplicationFiled: December 18, 2018Publication date: May 16, 2019Applicant: VIAVI SOLUTIONS INC.Inventors: Johannes SEYDEL, Mark TEVIS, Kangning LIANG, Jeffrey James KUNA, Jaroslaw ZIEBA, Paul Thomas KOHLMANN
-
Patent number: 10207479Abstract: An article including a magnetic-containing layer having a first surface and a second surface opposite the first; a first reflector layer external to the first surface of the magnetic-containing layer; a second reflector layer external to the second surface of the magnetic-containing layer; a first selective light modulator layer external to the first reflector layer; a second selective light modulator layer external to the second reflector layer; a first absorber layer external to the first selective light modulator layer; and a second absorber layer external to the second selective light modulator layer; wherein at least one of the first and second selective light modulator layers comprises at least one of a curing agent, and at least one coating aid is disclosed. Methods of making the disclosed article are also disclosed.Type: GrantFiled: June 26, 2017Date of Patent: February 19, 2019Assignee: VIAVI SOLUTIONS INC.Inventors: Johannes Seydel, Mark Tevis, Kangning Liang, Jeffrey James Kuna, Jaroslaw Zieba, Paul Thomas Kohlmann